Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
Next >
Amgen stock falls as analysts mull over weight loss drug’s bone density data
November 12, 2024
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
Health care industry
Viking Therapeutics Inc
LILLY DRN
From
CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
October 31, 2024
Tags
Social issues
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Medical research
From
CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
October 23, 2024
Tickers
HIMS
LLY
NEWS
NVO
Tags
News
wegovy
Shivdeep Dhaliwal
From
Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
Amazon/com Inc
Social issues
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags
LILLY DRN
Healthy Returns
Health care industry
From
CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
October 14, 2024
Tags
Mad Money
S&P 500
Uranium Energy Corp
From
CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
Tags
LILLY DRN
Pharmaceuticals
Zealand Pharma A/S
From
CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
October 09, 2024
Tags
Health care industry
Business
World News
From
CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
October 04, 2024
Tickers
JOBS
OIL
Tags
Novo Nordisk A/S
Oil
Markets
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
Tags
Constellation Energy Corp
NVIDIA Corp
Palantir Technologies Inc
From
CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
October 01, 2024
Tags
Labor unions
Strikes
ICU Medical Inc
From
CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
October 01, 2024
Tags
Economy
Home Depot Inc
US Economy
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
Tags
Science
Business
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Wednesday
September 25, 2024
Tags
Business News
Investing
Economy
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Health & Science
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
September 24, 2024
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
September 23, 2024
Tags
Advance Auto Parts Inc
Investment strategy
Novo Nordisk A/S
From
CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
September 22, 2024
Tickers
NEWS
NVO
Tags
Benzinga
Zain Rizvi
General
From
Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
Tags
Cigna Corp
Health care industry
Eli Lilly and Co
From
CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
Tags
Health care industry
Novartis AG
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Health care industry
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
September 16, 2024
Tags
Meta Platforms Inc
Breaking News: Business
US: News
From
CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
September 12, 2024
Tickers
JOBS
Tags
Prices
Jobs
Inflation
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Social issues
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Health care industry
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.